样式: 排序: IF: - GO 导出 标记为已读
-
Paediatric percutaneous nephrolithotomy (P-PCNL) reporting checklist. Scand. J. Urol. (IF 1.5) Pub Date : 2023-11-21 Patrick Juliebø-Jones,Øyvind Ulvik,Christian Beisland,Bhaskar K Somani
OBJECTIVE To develop a reporting checklist that serves to improve and standardise reporting in studies pertaining to paediatric percutaneous nephrolithotomy (PCNL). METHODS Based on findings from systematic review of literature, a draft list of items was formulated. By process of review and revisions, a finalised version was established and consensus achieved. RESULTS The finalised version of the checklist
-
Abandoning testing for asymptomatic microscopic haematuria in Sweden - a long-term follow-up. Scand. J. Urol. (IF 1.5) Pub Date : 2023-11-21 Per-Uno Malmström,Gårdmark Truls
OBJECTIVES To test the hypothesis that the Swedish national policy of abandoning testing for asymptomatic microscopic haematuria (AMH) introduced in 1999 did not adversely affect the prognosis of patients with urinary bladder cancer. Specific aims were to investigate possible effects on (1) Diagnostic delay as represented by stage distribution at diagnosis, (2) Survival and mortality trends, also in
-
Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden. Scand. J. Urol. (IF 1.5) Pub Date : 2023-11-10 Rolf Gedeborg,Fredrik Sandin,Camilla Thellenberg-Karlsson,Johan Styrke,Ingela Franck Lissbrant,Hans Garmo,Pär Stattin
BACKGROUND Randomised controlled trials have demonstrated prolonged survival with new upfront treatments in addition to standard androgen deprivation therapy (ADT) in men with de novo metastatic castration-sensitive prostate cancer. We describe patient characteristics, time trends and regional differences in uptake of these new treatment strategies in clinical practice. MATERIAL AND METHODS This descriptive
-
Initial management and survival of patients with primary metastatic bladder cancer before the immunotherapy era: a population-based study from Norway. Scand. J. Urol. (IF 1.5) Pub Date : 2023-11-10 Christina Tanem Møller,Gunnar Tafjord,Augun Blindheim,Viktor Berge,Sophie Fosså,Bettina Kulle Andreassen
Before immunotherapy became part of the management of metastatic bladder cancer (mBC), systemic anti-cancer treatment comprised primarily of platinum-based chemotherapy. The objective of this study was to describe the characteristics, the initial management, overall survival (OS) and hospitalisations of patients with mBC before 2018 when immunotherapy for mBC was introduced in Norway. Material and
-
Long-term efficacy of selective arterial embolisation of renal angiomyolipoma. Scand. J. Urol. (IF 1.5) Pub Date : 2023-10-31 Jesper Swärd,Karl Bohlin,Olof Henrikson,Sven Lundstam,Ralph Peeker,Anna Grenabo Bergdahl
OBJECTIVE To evaluate the long-term efficacy of selective arterial embolisation in renal angiomyolipoma (AML), with emphasis on tumour shrinkage, potential regrowth and the necessity of supplementary procedures. Material and methods: A retrospective review of all 58 consecutive embolisations at two institutions, between 1999 and 2018, was performed. Clinical notes, laboratory data and imaging were
-
First population-level results of pre-biopsy prostate MRI. Scand. J. Urol. (IF 1.5) Pub Date : 2023-09-28 Ola Bratt
-
Health-related quality of life prior to and 1 year after radical cystectomy evaluated with FACT-G and FACT-VCI questionnaires. Scand. J. Urol. (IF 1.5) Pub Date : 2023-09-21 Anna Karin Lind,Fredrik Liedberg,Firas Aljabery,Mats Bläckberg,Truls Gårdmark,Abofazl Hosseini,Tomas Jerlström,Viveka Ströck,Karin Stenzelius
OBJECTIVE The aim of this study was to investigate health-related quality of life (HRQoL) before and 1 year after radical cystectomy in relation to age and gender. METHODS This prospective study involves 112 men and 40 women with bladder cancer treated with radical cystectomy between 2015 and 2018. HRQoL was assessed preoperatively and 1 year post-surgery through Functional Assessment of Cancer Therapy
-
External beam radiotherapy of prostate cancer with or without high dose-rate brachytherapy: the Norwegian experience with long-term urinary and bowel adverse effects. Scand. J. Urol. (IF 1.5) Pub Date : 2023-08-30 Trude B Wedde,Milada C Smaastuen,Kari Vatne,Melanie Birthe Schulz-Jaavall,Sophie D Fosså,Wolfgang Lh Lilleby
BACKGROUND There are few studies utilizing the Expanded Prostate Index Composite questionnaire-26 (EPIC-26) questionnaire to examine the long-term association between Domain Summary Scores (DSSs) and Quality of Life (QoL) after External Beam Radiation Therapy (EBRT, 3DCRT [3D conventional radiotherapy]/IMRT [intensity modulated radiation therapy]) versus EBRT combined with High-Dose-Rate Brachytherapy
-
The influence of secondary resection using NeuroSAFE-technique on sexual function in unilateral nerve-sparing robot-assisted laparoscopic prostatectomies. Scand. J. Urol. (IF 1.5) Pub Date : 2023-08-28 Mirjam Naomi Mohr,Annemarie Uhlig,Hannah Maria Ploeger,Oliver Hahn,Lutz Trojan,Mathias Reichert
OBJECTIVE To demonstrate the surgical influence of secondary resection on sexual function in finally unilateral nerve-sparing robot- assisted laparoscopic prostatectomies (RALPs) performed with the 'neurovascular structure-adjacent frozen-section examination' (NeuroSAFE) technique by prospectively collecting EPIC-26-questionnaires. MATERIAL & METHODS Sexual function status measured by the sexual-symptom-score
-
Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019. Scand. J. Urol. (IF 1.5) Pub Date : 2023-08-27 Victoria K Znaider,Lauge H Mikkelsen,Christian Fuglesang S Jensen,Jens Sønksen,Steffen Heegaard
PURPOSE To describe the epidemiologic, clinical, histopathological, and genetic features of primary mucosal melanoma of the urinary tract in a national Danish cohort with cases included from the year 1990 to 2019. MATERIAL AND METHODS Patients of the Danish cohort were found using national databases. Only primary tumours were included in the cohort. Appropriate formalin-fixed paraffin-embedded blocks
-
A randomised study of TURP after intraprostatic injection of mepicacaine/adrenaline versus regular TURP in patients with LUTS/BPO. Scand. J. Urol. (IF 1.5) Pub Date : 2023-08-24 Fredrik Stenmark,Lars Brundin,Olof Gunnarsson,Henrik Kjölhede,Edvard Lekås,Ralph Peeker,Marianne Månsson,Jonas Richthoff,Johan Stranne
INTRODUCTION During transurethral resection of the prostate (TURP), the most established surgical treatment of lower urinary tract symptoms (LUTS) due to benign prostatic obstruction (BPO), the prostate can bleed profusely, bringing about anaemia and compromised oxygen delivery to the entire body. OBJECTIVE The primary objective of this study was to assess the efficacy of mepivacaine and adrenaline
-
Predictors for complication in renal cancer surgery: a national register study. Scand. J. Urol. (IF 1.5) Pub Date : 2023-08-21 John Åkerlund,Pernilla Sundqvist,Börje Ljungberg,Sven Lundstam,Ralph Peeker,Marianne Månsson,Anna Grenabo Bergdahl
OBJECTIVE Nationwide register data provide unique opportunities for real-world assessment of complications from different surgical methods. This study aimed to assess incidence of, and predictors for, post-operative complications and to evaluate 90-day mortality following different surgical procedures and thermal ablation for renal cell carcinoma (RCC). MATERIAL AND METHODS All patients undergoing
-
Abstract book for the 34th Congress of the Scandinavian Association of Urology (NUF). Scand. J. Urol. (IF 1.5) Pub Date : 2023-08-13
June 7-10th, 2023 Bergen, Norway.
-
Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study. Scand. J. Urol. (IF 1.5) Pub Date : 2023-08-08 Martin Holmbom,Jon Forsberg,Mats Fredrikson,Maud Nilsson,Lennart E Nilsson,Håkan Hanberger,Anita Hällgren
BACKGROUND Infection of the prostate gland following biopsy, usually with Escherichia coli, is a common complication, despite the use of antimicrobial prophylaxis. A fluoroquinolone (FQ) is commonly prescribed as prophylaxis. Worryingly, the rate of fluoroquinolone-resistant (FQ-R) E. coli species has been shown to be increasing. OBJECTIVE This study aimed to identify risk factors associated with infection
-
Long-term patient follow-up should be routinely implemented in radiotherapy units to detect late adverse effects after cancer treatment. Scand. J. Urol. (IF 1.5) Pub Date : 2023-08-07 Kirsti Aas,Amir Sherif
Editorial comment to Urosymphyseal fistula after pelvic radiotherapy - an entity in patients with significant comorbidity requiring multidisciplinary management Scand J Urol. 2023.
-
Taking the temperature: a case of urethral polyembolokoilamania. Scand. J. Urol. (IF 1.5) Pub Date : 2023-07-10 Kristian Lyngholm Strand,Jan Maciej Krzak
-
Current evidence for moderate and ultra-hypofractionated radiation therapy in prostate cancer: a summary of the results from phase 3 randomised trials. Scand. J. Urol. (IF 1.5) Pub Date : 2023-06-20 Oscar Lilleby,Peter Meidahl Petersen,Gedske Daugaard,Katharina Anne Perell
PROBLEM A low α/β ratio for prostate cancer (PCa) compared to surrounding normal tissue theoretically implies therapeutical advantages with hypofractionated treatment. Data from large randomised control trials (RCTs) comparing moderate hypofractionated (MHRT, 2.4-3.4 Gray/fraction (Gy/fx)) and ultra-hypofractionated (UHRT, >5 Gy/fx) with conventionally fractionated radiation therapy (CFRT, 1.8-2 Gy/fx)
-
Salvage radiotherapy after radical prostatectomy: functional outcomes in the LAPPRO trial after 8-year follow-up. Scand. J. Urol. (IF 1.5) Pub Date : 2023-05-11 Stefan Carlsson,David Bock,Anna Lantz,Eva Angenete,Katarina Koss Modig,Jonas Hugosson,Anders Bjartell,Gunnar Steineck,Peter Wiklund,Eva Haglind
OBJECTIVE Radical prostatectomy reduces mortality among patients with localized prostate cancer, however up to 35% of patients will experience biochemical recurrence, often treated with salvage radiotherapy. The objective of the study was to investigate long-term effects of salvage radiotherapy. METHODS A prospective, controlled, non-randomized trial at 14 Swedish center's including 4,003 patients
-
Urosymphyseal fistula after pelvic radiotherapy in a tertial referral centre - a rare entity with significant comorbidity requiring multidisciplinary management. Scand. J. Urol. (IF 1.5) Pub Date : 2023-04-24 Johan Brändstedt,Johan Abrahamsson,Gediminas Baseckas,Johannes Bobjer,Axel Gerdtsson,Adalstein Gunnlaugsson,Petter Kollberg,Marie-Louise Lydrup,Martin Nyberg,Daniel Wenger,Anne Sörenby,Johan Tham,Åsa Warnolf,Fredrik Liedberg
OBJECTIVE To report population-based clinical presentation and outcomes in patients with urosymphyseal fistula (USF) after pelvic radiotherapy (RT). PATIENTS AND METHODS A retrospective chart review was performed in 33 consecutive patients diagnosed with suspicion of USF in a tertial referral center from 2014-2022 to ascertain information about diagnostic delay, clinical presentation, precipitating
-
First diagnostic results from Gothenburg-2 screening trial. Scand. J. Urol. (IF 1.5) Pub Date : 2023-04-12 Ola Bratt,Anssi Auvinen
-
Welcome to the new Scandinavian Journal of Urology! Scand. J. Urol. (IF 1.5) Pub Date : 2023-04-03 Pär Stattin
-
Thanks and good bye Taylor & Francis, authors and readers see you at Scand J Urol’s new website! Scand. J. Urol. (IF 1.5) Pub Date : 2023-02-24 Pär Stattin
Published in Scandinavian Journal of Urology (Vol. 57, No. 1-6, 2023)
-
Salvage HDR brachytherapy for prostate cancer: a high-volume center experience on 100 consecutive patients Scand. J. Urol. (IF 1.5) Pub Date : 2023-02-01 Lauri Mäkelä, Robin Bergroth, Lauri Taipale, Sara Tornberg, Harri Visapää
Abstract Aim This study aims to evaluate the safety and efficacy of salvage HDR brachytherapy in patients who have undergone a thorough diagnostic process. Materials and methods 100 prostate cancer patients – locally relapsed after previous radiotherapy – were treated with salvage HDR brachytherapy to a total dose of 24 Gy. Before treatment, the patients underwent PET imaging, prostate MRI, and prostate
-
Impact of ischemia time during partial nephrectomy on short- and long-term renal function Scand. J. Urol. (IF 1.5) Pub Date : 2023-01-28 Mikkel Rodin Deutch, Thomas Karmark Dreyer, Tau Pelant, Jørgen Bjerggaard Jensen
Abstract Objective Partial nephrectomy is the gold standard treatment in small renal tumours. During partial nephrectomy, the renal artery is clamped which creates transient ischemia. This can damage nephrons and may affect kidney function immediately postoperatively and on long-term. In the present study, we investigated the effect of ischemia time during partial nephrectomy with regards to affection
-
External validation of a simplified prognostic model for survival in patients with extrinsic malignant ureteral obstruction treated with tandem ureteral stents – a retrospective cohort study Scand. J. Urol. (IF 1.5) Pub Date : 2023-01-28 Reuben Ben-David, Yotam Veredgorn, Ziv Savin, Yuval Bar-Yosef, Ofer Yossepowitch, Mario Sofer, Roy Mano
Abstract Introduction Prognostic models of survival can identify patients with extrinsic malignant ureteral obstruction who will benefit from long-term drainage as offered by tandem ureteral stents. The study aims to validate a simplified prognostic model published by Cordeiro et al. and to identify additional prognostic predictors in a cohort of patients drained solely with tandem ureteral stents
-
Incidence and associated risk factors of venous thromboembolism after open and laparoscopic partial nephrectomy in patients administered short-period thromboprophylaxis: a Danish nationwide population-based cohort study Scand. J. Urol. (IF 1.5) Pub Date : 2023-01-26 Nessn H. Azawi, Sara Tolouee, Saeed Dabestani
Abstract Objective To report the risk of venous thromboembolism (VTE) after partial nephrectomy in Denmark. Materials and methods A nationwide population-based registry was used to conduct a retrospective cohort study. All partial nephrectomies from January 2010 to August 2018 were assessed for postoperative VTE events. Univariable and multivariable analyses were used to evaluate the odds of postoperative
-
Onset of androgen deprivation therapy leads to rapid deterioration of body composition, physical performance, cardiometabolic health and quality-of-life in prostate cancer patients Scand. J. Urol. (IF 1.5) Pub Date : 2023-01-26 Maarten Overkamp, Lisanne H. P. Houben, Saskia van der Meer, Joep G. H. van Roermund, Ronald Bos, Arjan P. J. Kokshoorn, Mads S. Larsen, Luc J. C. van Loon, Milou Beelen, Sandra Beijer
Abstract Objectives To assess the adverse impact of the first 5 months of androgen deprivation therapy on body composition, physical performance, cardiometabolic health and health-related quality-of-life in prostate cancer patients. Materials and Methods Thirty-four prostate cancer patients (70 ± 7 years) were assessed shortly after initiation of androgen deprivation therapy and again 5 months thereafter
-
Low-volume grade group 2 prostate cancer candidates for active surveillance: a radical prostatectomy retrospective analysis Scand. J. Urol. (IF 1.5) Pub Date : 2023-01-23 Johan Björklund, Douglas C. Cheung, Lisa J. Martin, Maria Komisarenko, Katharine Lajkosz, Robert J. Hamilton, Alexandre R. Zlotta, Antonio Finelli
Abstract Objective Guidelines support considering selected men with ISUP grade group (GG) 2 prostate cancer for active surveillance (AS). We assessed the association of clinical variables with unfavorable pathology at radical prostatectomy in low-volume GG 2 prostate cancer on biopsy in a retrospective cohort. Materials and methods This was a retrospective analysis of 378 men with low-volume (≤ 2 cores)
-
Incidence of erectile dysfunction treatment after radical prostatectomy by Statin use in Finnish Nationwide Cohort Study Scand. J. Urol. (IF 1.5) Pub Date : 2023-01-23 Roni M. Joentausta, Aino Siltari, Antti Rannikko, Teemu J. Murtola
Abstract Background Erectile dysfunction (ED) is common after radical prostatectomy (RP) due to cavernous nerve damage. Risk of ED is also affected by vascular function. Statins prevent vascular events but their association with post-prostatectomy ED is unclear. We explored the likelihood of starting ED treatment after RP by statin use at the population level. Methods The study cohort included 14,295
-
Assessment of complications after transperineal and transrectal prostate biopsy using a risk-stratified pathway identifying patients at risk for post-biopsy infections Scand. J. Urol. (IF 1.5) Pub Date : 2023-01-19 Sebastian Berg, Karl Heinrich Tully, Vincent Hoffmann, Henning Bahlburg, Florian Roghmann, Guido Müller, Joachim Noldus, Moritz Reike
Abstract Introduction Evidence of transperineal (TP) superiority over transrectal (TR) biopsy is growing due to lower infectious complication rates. However, TR biopsy is the most common procedure, and it seems that a cross-over to TP is delayed by logistical challenges such as costs, complexity, and lack of experience. We investigate whether well-selected patients without any risk factors may further
-
The association between gender, stage and prognosis in bladder cancer patients undergoing radical cystectomy Scand. J. Urol. (IF 1.5) Pub Date : 2023-01-16 Mathilde Sofie Secher, Josephine Hyldgaard, Jørgen Bjerggaard Jensen
Abstract Objective The incidence of bladder cancer is three times as high in men compared to women. Moreover, women are generally diagnosed with a more severe tumor stage and have poorer prognosis. This study aimed to examine the association between gender, stage, and prognosis among a subgroup of bladder cancer patients treated with radical cystectomy. Patients and methods A total of 460 patients
-
Readmissions after radical nephrectomy in a national cohort Scand. J. Urol. (IF 1.5) Pub Date : 2023-01-16 Joaquin Michel, Dhaval Jivanji, Alexander N. Goel, Patrick M. Lec, Andrew T. Lenis, Mark S. Litwin, Karim Chamie
Abstract Objective To analyze the factors and costs associated with 30-day readmissions for patients undergoing radical nephrectomy. Materials and Methods We used the 2014 Nationwide Readmission Database to identify adults who underwent radical nephrectomy for renal cancer, stratified by surgical approach. We determined patient factors associated with readmission rates, diagnoses, and costs using multivariate
-
Feasibility of minimally invasive, same-day injection of autologous adipose-derived stem cells in the treatment of erectile dysfunction Scand. J. Urol. (IF 1.5) Pub Date : 2022-12-31 Mikkel Fode, Naomi Nadler, Lars Lund, Nessn Azawi
Abstract Objective To investigate feasibility and safety of a new minimally invasive same-day method of autologous adipose derived stem cell (ADSC) transplantation in men suffering from ED. Materials and methods Prospective case series of 10 men with an IIEF-EF domain score <17. The IIEF questionnaire was filled out at baseline and 1, 2 and 3 months after treatment. Side effects were assessed by investigations
-
Women’s experience of sexuality after radical cystectomy – a qualitative study Scand. J. Urol. (IF 1.5) Pub Date : 2022-12-27 Annica Löfgren, Karin Stenzelius, Fredrik Liedberg, Anne-Marie Wangel
Abstract Purpose The aim of this study was to explore how women experienced sexuality after radical cystectomy due to bladder cancer. Methods We performed an interview study with qualitative design with content analysis. Inclusion criteria were age below 75 years. In total 10 women, with a median age of 64 years at surgery, were interviewed at median 24 months post radical cystectomy. Results The 10
-
UROSCAN and UROSCANSEQ: a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice – from biobank to RNA-sequencing in real time Scand. J. Urol. (IF 1.5) Pub Date : 2022-12-20 Fredrik Liedberg, Johan Abrahamsson, Carina Bernardo, Mats Bläckberg, Anders Edsjö, Markus Heidenblad, Christer Larsson, Gottfrid Sjödahl, Pontus Eriksson
Abstract Background Bladder cancer is molecularly one of the most heterogenous malignancies characterized by equally heterogenous clinical outcomes. Standard morphological assessment with pathology and added immunohistochemical analyses is unable to fully address the heterogeneity, but up to now treatment decisions have been made based on such information only. Bladder cancer molecular subtypes will
-
Predictive characteristics for disease recurrence and overall survival in non-metastatic clinical T1 renal cell carcinoma – results from the National Swedish Kidney Cancer Register Scand. J. Urol. (IF 1.5) Pub Date : 2022-12-15 Tarik Almdalal, Andreas Karlsson Rosenblad, Mikael Hellström, Anders Kjellman, Per Lindblad, Sven Lundstam, Pernilla Sundqvist, Börje Ljungberg
Abstract Objective Patients with clinical T1 renal cell carcinoma (cT1RCC) have risks for recurrence and reduced overall survival despite being in the best prognostic group. This study aimed to evaluate the association of different treatments on disease recurrence and overall survival using clinical and pathological characteristics in a nation-wide cT1RCC cohort. Materials and methods A total of 4
-
Register-based research. Accurate data and analysis, crucial for correct conclusions. Comment on “Incidence, mortality, and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019” Scand. J. Urol. (IF 1.5) Pub Date : 2022-12-08 Marianne Brehmer
Published in Scandinavian Journal of Urology (Vol. 57, No. 1-6, 2023)
-
The effect of povidone-iodine rectal cleansing on post-biopsy infectious complications Scand. J. Urol. (IF 1.5) Pub Date : 2022-12-01 Coşkun Bostancı, Ufuk Bozkurt
Abstract Objective To evaluate the effect of pre-biopsy povidone-iodine rectal cleansing on post-biopsy hospitalization rates due to prostate biopsy-related infectious complications. Material and methods In this retrospective study, we reviewed 552 patients who underwent ultrasonography-guided transrectal prostate biopsy between 2014 and 2022. Group 1, 361 patients (January 2014–October 2020) were
-
Non-transecting urethroplasty in patients with bulbar urethral strictures shorter than three centimeters Scand. J. Urol. (IF 1.5) Pub Date : 2022-12-01 Muhammet Şahin Yılmaz, Alihan Kokurcan, Fahrettin Şamil Uysal, Görkem Özenç, Fatih Yalçınkaya
Abstract Purpose This study aimed to compare the success and postoperative complication rates of the novel non-transecting urethroplasty (NTU) technique and conventional excision-primary anastomosis (EPA) in the surgical treatment of short bulbar urethral strictures. Material and methods Data of the patients who underwent excision-primary anastomosis or NTU procedures at our center for the surgical
-
Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019 Scand. J. Urol. (IF 1.5) Pub Date : 2022-11-23 Eemil Karttunen, Petteri Hervonen, Abolfazl Hosseini Aliabad, Jan Oldenburg, Helle Pappot, Jukka Sairanen, Henrik Støvring, Juan Luis Vásquez, Suzanne Bergman, Gry Magnussen, Pernille Norremark, Steinar Thoresen, Anders Ullén
Abstract Purpose To understand the potential impact of new treatment options for urinary tract cancer, recent population trends in incidence, mortality and survival should be elucidated. This study estimated changes in the incidence, mortality and relative survival of urinary tract cancer in the Nordic countries (Denmark, Finland, Iceland, Norway and Sweden) between 1990 and 2019. Methods Annual counts
-
Isolated monkeypox genital lesions Scand. J. Urol. (IF 1.5) Pub Date : 2022-11-02 Mohamad Abou Chakra, Igor Duquesne, Ahmad Bou Yassine, Elie Hanna, Nicolas Barry Delongchamps, Moutassem Jida, Michael Peyromaure
Published in Scandinavian Journal of Urology (Vol. 57, No. 1-6, 2023)
-
Lower urinary tract injuries in patients with pelvic fractures at a level 1 trauma center – an 11-year experience Scand. J. Urol. (IF 1.5) Pub Date : 2022-11-02 Lasse Rehné Jensen, Andreas Røder, Emma Possfelt-Møller, Upender Martin Singh, Mikael Aagaard, Allan Evald Nielsen, Lars Bo Svendsen, Luit Penninga
Abstract Background Urological injuries can occur in patients with pelvic fractures. Treatment recommendations lack solid evidence and is often pragmatical. There is a continuous need to describe short- and long-term morbidity following lower urinary tract trauma. Objective To describe incidence, diagnosis, treatment, and morbidity following lower urinary tract injuries in pelvic fractures. Patients
-
Facing urosepsis- the most deadly of all urological diseases Scand. J. Urol. (IF 1.5) Pub Date : 2022-10-31 Truls E. Bjerklund Johansen, Tommaso Cai
Published in Scandinavian Journal of Urology (Vol. 56, No. 5-6, 2022)
-
The pursuit of excellence Scand. J. Urol. (IF 1.5) Pub Date : 2022-10-24 Jonathan Aning
Published in Scandinavian Journal of Urology (Vol. 56, No. 5-6, 2022)
-
Community-onset urosepsis: incidence and risk factors for 30-day mortality – a retrospective cohort study Scand. J. Urol. (IF 1.5) Pub Date : 2022-09-20 Martin Holmbom, Maria Andersson, Magnus Grabe, Ralph Peeker, Aus Saudi, Johan Styrke, Firas Aljabery
Abstract Background Urosepsis is a life-threatening condition that needs to be addressed without delay. Two critical issues in its management are: (1) Appropriate empirical antibiotic therapy, considering the patients general condition, comorbidity, and the pathogen expected; and (2) Timing of imaging to identify obstruction requiring decompression. Objectives To identify risk factors associated with
-
Watch out for sticky diagnosis bias in older men with prostate cancer Scand. J. Urol. (IF 1.5) Pub Date : 2022-09-18 Oskar Bergengren, Marcus Westerberg
Published in Scandinavian Journal of Urology (Vol. 56, No. 5-6, 2022)
-
Implementation of sacral neuromodulation for urinary indications. A Danish prospective study during the initial 15 months of a new service in a tertiary referral hospital Scand. J. Urol. (IF 1.5) Pub Date : 2022-09-09 Hanne Kobberø, Margrethe Andersen, Karin Andersen, Torben Brøchner Pedersen, Mads Hvid Poulsen
Abstract Objective Sacral neuromodulation (SNM) is a well-established treatment modality for idiopathic overactive bladder and urgency incontinence, idiopathic fecal incontinence and non-obstructive urinary retention. This study describes the start-up phase of establishing the SNM service. Primary objective: To investigate the patient-reported outcome measures of SNM on lower urinary tract dysfunction
-
Kidney tumor biopsy – an unmet need for personalized treatment Scand. J. Urol. (IF 1.5) Pub Date : 2022-09-08 Börje Ljungberg
Published in Scandinavian Journal of Urology (Vol. 56, No. 5-6, 2022)
-
Evidence of overestimating prostate cancer mortality in Estonia: a population-based study Scand. J. Urol. (IF 1.5) Pub Date : 2022-09-08 Kaire Innos, Keiu Paapsi, Indrek Alas, Peep Baum, Martin Kivi, Mihhail Kovtun, Rauno Okas, Helis Pokker, Olga Rajevskaja, Aleksandra Rautio, Mikk Saretok, Elari Valk, Mihhail Žarkovski, Gleb Denissov, Katrin Lang
Abstract Background Prostate cancer (PC) mortality statistics in Estonia has shown inconsistencies with incidence and survival trends. The aim of this population-based study was to assess the accuracy of reporting PC as the underlying cause of death and estimate the effect of misattribution in assigning cause of death on PC mortality rates. Material and methods The Estonian Causes of Death Registry
-
The clinical consequences of routine 68Ga-PSMA-11 PET/CT in patients with newly diagnosed prostate cancer, ISUP grade 5 and no metastases based on standard imaging – preliminary results Scand. J. Urol. (IF 1.5) Pub Date : 2022-09-08 Helle D. Zacho, Surenth Nalliah, Astrid Petersen, Lars J. Petersen
Abstract Aim To evaluate the clinical consequences of prostate specific membrane antigen (PSMA) PET/CT for primary staging in patients with ISUP grade 5 (Gleason score ≥9) prostate cancer (PCa), and no definitive distant metastases based on standard imaging. Methods At our tertial referral center, PSMA PET/CT became standard of care from August 2018 for primary staging of prostate cancer given the
-
Surgeon volume and patient-reported urinary incontinence after radical prostatectomy. Population-based register study in Sweden Scand. J. Urol. (IF 1.5) Pub Date : 2022-09-06 Rebecka Arnsrud Godtman, Erik Persson, Oskar Bergengren, Stefan Carlsson, Eva Johansson, David Robinsson, Jonas Hugosson, Pär Stattin
Abstract Objective To investigate the association between surgeon volume and urinary incontinence after radical prostatectomy. Methods A total of 8326 men in The National Prostate Cancer Register of Sweden (NPCR) underwent robot-assisted radical prostatectomy (RARP) between 2017 and 2019 of whom 56% (4668/8 326) had responded to a questionnaire one year after RARP. The questionnaire included the question:
-
A new important tool to report and analyse adverse incidents that all urologists should use Editorial comment to: Nisen H, Erkkilä K, Ettala O, Ronkainen H, et al. Intraoperative complications in kidney tumor surgery: critical grading for the European Association of Urology intraoperative adverse incident classification. Scand J Urol. 2022 Jun 22:1–8 Scand. J. Urol. (IF 1.5) Pub Date : 2022-09-06 Lars Lund
Published in Scandinavian Journal of Urology (Vol. 56, No. 5-6, 2022)
-
99mTc-Sestamibi SPECT/CT and histopathological features of oncocytic renal neoplasia Scand. J. Urol. (IF 1.5) Pub Date : 2022-09-05 Antonios Tzortzakakis, Thomas Papathomas, Ove Gustafsson, Stefan Gabrielson, Kiril Trpkov, Linnea Ekström-Ehn, Alexandros Arvanitis, Maria Holstensson, Mattias Karlsson, Georgia Kokaraki, Rimma Axelsson
Abstract Background 99mTc-Sestamibi Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) contributes to the non-invasive differentiation of renal oncocytoma (RO) from renal cell carcinoma (RCC) by characterising renal tumours as Sestamibi positive or Sestamibi negative regarding their 99mTc-Sestamibi uptake compared to the non-tumoral renal parenchyma. Purpose To determine whether
-
Surgical experience is predictive for bladder tumour resection quality Scand. J. Urol. (IF 1.5) Pub Date : 2022-09-05 Sarah H. Bube, Rasmus Brix, Maya B. Christensen, Mathias Thostrup, Søren Grimstrup, Rikke B. Hansen, Claus Dahl, Lars Konge, Nessn Azawi
Abstract Objectives To assess the resection quality of transurethral bladder tumour resection (TURBT) and the association to surgeon experience depending on the presence of detrusor muscle. Methods A retrospective study on 640 TURBT procedures performed at Zealand University Hospital, Denmark, from 1 January 2015 − 31 December 2016. Data included patient characteristics, procedure type, surgeon category
-
Biochemical recurrence after radical prostatectomy – a large, comprehensive, population-based study with long follow-up Scand. J. Urol. (IF 1.5) Pub Date : 2022-08-21 Elin Axén, Johan Stranne, Marianne Månsson, Erik Holmberg, Rebecka Arnsrud Godtman
Abstract Objective We evaluated long-term risk for biochemical recurrence and subsequent prognosis in a population-based cohort. Material and Methods We used register-based data to evaluate 6 675 consecutive patients having radical prostatectomy in Västra Götaland county in Sweden during 1995–2014. Patients were followed until death or end of study, 31 December 2014. Data were collected from registers
-
How to survey adherence to guidelines by use of clinical cancer registers Scand. J. Urol. (IF 1.5) Pub Date : 2022-08-21 Pär Stattin
Published in Scandinavian Journal of Urology (Vol. 56, No. 4, 2022)
-
Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma Scand. J. Urol. (IF 1.5) Pub Date : 2022-08-18 Andreas Karlsson Rosenblad, Pernilla Sundqvist, Ulrika Harmenberg, Mikael Hellström, Fabian Hofmann, Anders Kjellman, Britt-Inger Kröger Dahlin, Per Lindblad, Magnus Lindskog, Sven Lundstam, Börje Ljungberg
Abstract Objective To examine the association between surgical waiting times (SWTs) and all-cause mortality (ACM) in non-metastatic patients with RCC, in relation to tumour stage. Patients and methods This nation-wide population-based cohort study included 9,918 M0 RCC patients registered in the National Swedish Kidney Cancer Register, between 2009 and 2021, followed-up for ACM until 9 December 2021
-
S-phase – an independent prognostic marker in upper tract urothelial carcinoma Scand. J. Urol. (IF 1.5) Pub Date : 2022-08-15 Camilla Malm, Georg Jaremko, Marianne Brehmer
Abstract Objectives To evaluate S-phase fraction as a predictor of invasiveness and cancer-specific survival in upper tract urothelial carcinoma (UTUC). Patients and methods One hundred and fifteen patients having undergone radical nephroureterectomy were analysed with histology in radical nephroureterectomy specimens as reference test and S-phase fraction as index test. Ploidy and S-phase were determined
-
Treatment with CoreTherm in 570 patients with prostate volumes of 80-366 ml: an evaluation of short- and long-term retreatment risk Scand. J. Urol. (IF 1.5) Pub Date : 2022-08-08 Fredrik Stenmark, Lars Brudin, Henrik Kjölhede, Ralph Peeker, Johan Stranne
Abstract Introduction CoreTherm (ProstaLund AB, Lund, Sweden) is an outpatient treatment option in men with lower urinary tract symptoms and catheter-dependent men with chronic urinary retention caused by benign prostatic obstruction (BPO). CoreTherm is high-energy transurethral microwave thermotherapy with feedback technique. Modern treatment with CoreTherm includes transurethral intraprostatic injections
-
Evaluation of the relation between size of stone and its attenuation measured by Hounsfield units and the total laser energy required to fragment it Scand. J. Urol. (IF 1.5) Pub Date : 2022-08-05 Mohamed Saad Elsayed, Mohamed Esmat Abo Ghareeb, Hany Hamed, Mohamed Elmoazen, Ahmed Amr Shorbagy
Abstract Background Anticipating the total laser energy (TLE) of Holmium YAG laser required for ureteroscopic (URS) lithotripsy is essential to guide urologists in selecting the optimal fiber size. This study aimed at evaluating the relationship between stone size and stone attenuation measured by HU as predictors for the TLE during the procedure. Methods We conducted an observational prospective cohort